Revance Therapeutics, Inc. (RVNC) by event type
RVNC moves most on price-target cuts — a median of +0.33% at 30 minutes across 19 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the RVNC overview →
How RVNC reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades 1,295 of 2,603 | 20 | 0.00% | 45% | +0.30% |
| Coverage initiations 831 of 2,283 | 23 | +0.13% | 57% | 0.00% |
| Rating reiterations 526 of 3,522 | 37 | +0.17% | 65% | +0.30% |
| Price-target cuts 110 of 1,527 | 19 | +0.33% | 63% | +0.17% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 1 further class was observed with fewer than 10 measured events and is not published.
That’s how RVNC usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target cuts → · RVNC overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| PishPosh, Inc. (BABY) | 702 | 0.00% | 48% |
| Insmed Incorporated (INSM) | 701 | -0.08% | 45% |
| AB Corporate Bond ETF (EYEG) | 700 | 0.00% | 44% |
| STEMLINE THERAPEUTICS (STML) | 697 | +0.08% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.